These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 3485649

  • 21. Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH.
    Gam AN, Jensen GF, Hasselstrøm K, Olsen M, Nielsen KS.
    J Endocrinol Invest; 1991 Jun; 14(6):451-5. PubMed ID: 1774441
    [Abstract] [Full Text] [Related]

  • 22. Bone Gla protein and sex hormone-binding globulin in nontoxic goiter: parameters for metabolic status at the tissue level.
    Faber J, Perrild H, Johansen JS.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):49-55. PubMed ID: 2294139
    [Abstract] [Full Text] [Related]

  • 23. Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism.
    Ross DS, Ardisson LJ, Nussbaum SR, Meskell MJ.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):507-9. PubMed ID: 1991818
    [Abstract] [Full Text] [Related]

  • 24. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G, Mazziotti G, Sorvillo F, Piscopo M, Lalli E, Biondi B, Iorio S, Molinari A, Giustina A, Carella C.
    Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
    [Abstract] [Full Text] [Related]

  • 25. Clinical significance of serum bone Gla protein and urinary gamma-Gla as biochemical markers in primary hyperparathyroidism.
    Yoneda M, Takatsuki K, Oiso Y, Takano T, Kurokawa M, Ota A, Tomita A, Ohno T, Okano K, Kanazawa T.
    Endocrinol Jpn; 1986 Feb; 33(1):89-94. PubMed ID: 3487445
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Bone mass, bone turnover, calcium homeostasis, and body composition in surgically and radioiodine-treated former hyperthyroid patients.
    Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P.
    Thyroid; 1996 Jun; 6(3):169-75. PubMed ID: 8837322
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Serum levels of bone Gla-protein in normal humans and in patients with chronic renal failure.
    Sugimoto K, Dohi Y, Dohi K, Yonemasu K, Fujimoto J, Kanauchi M, Yamanaka F, Moriyama T, Ishikawa H.
    Miner Electrolyte Metab; 1987 Jun; 13(3):152-7. PubMed ID: 3498115
    [Abstract] [Full Text] [Related]

  • 31. [Serum activity of angiotensin-converting enzyme and osteocalcin levels in hyperthyroidism].
    Letizia C, Minisola S, Cerci S, Tarsitani P, De Ciocchis A, Scavo D.
    Minerva Endocrinol; 1992 Jun; 17(3):103-6. PubMed ID: 1338548
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Changes of bone and mineral metabolism in patients with hyperthyroidism before and after treatment].
    Chai R, Ye Z, Zhan Z.
    Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):682-4. PubMed ID: 11038794
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Serum osteocalcin and bone mineral metabolism following successful renal transplantation.
    Boiskin I, Epstein S, Ismail F, Thomas SB, Raja R.
    Clin Nephrol; 1989 Jun; 31(6):316-22. PubMed ID: 2665993
    [Abstract] [Full Text] [Related]

  • 38. Differences in serum bone GLA protein with age and sex.
    Epstein S, Poser J, McClintock R, Johnston CC, Bryce G, Hui S.
    Lancet; 1984 Feb 11; 1(8372):307-10. PubMed ID: 6141381
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.